Table 1 Patient Characteristics
Age | Disease | First diagnosis | Previous surgery | Previous sCT | Associated sCT | PIPAC procedure | |
|---|---|---|---|---|---|---|---|
Pat 1 | 62 | DMPM | April 2012 | 2 CRS + HIPEC | 1 line | – | 2 |
Pat 2 | 71 | EOC | September 2010 | ARR, ovarectomy, hysterectomy, omentectomy, lymphadenectomy | 7 lines | Topotecan (days 1, 8, 15) | 3 |
Pat 3 | 68 | CRC | May 2014 | Explorative laparotomy | 2 lines | Folfox + Cetuximab | 4 |
Pat 4 | 43 | PMP | August 2013 | Debulking | 2 lines + irinotecan IP | Folfoxiri | 4 |
Pat 5 | 61 | EOC | September 2012 | ARR, small bowel resection, ovarectomy, hysterectomy, omentectomy | 3 lines | Weekly paclitaxel | 3 |
Pat 6 | 39 | GC | December 2014 | Explorative laparotomy | 2 lines | Folfiri | 3 |
Pat 7 | 51 | GC | November 2013 | Gastric resection | 2 lines | Paclitaxel + ramucirumab | 3 |
Pat 8 | 47 | GC | July 2015 | Explorative laparoscopy | 1 line | Xelox | 3 |
Pat 9 | 53 | EOC | September 2014 | Ovarectomy, hysterectomy, | 2 lines | Paclitaxel | 2 |
Pat 10 | 78 | DMPM | April 2015 | Explorative laparoscopy | 1 line | Pemetrexed | 3 |
Pat 11 | 51 | CRC | August 2011 | CRS + HIPEC | 2 lines | Cetuximab | 2 |
Pat 12 | 55 | GC | January 2015 | Gastric resection, omentectomy, | 1 line | CDDP + teysuno | 2 |
Pat 13 | 45 | GC | December 2013 | Gastric resection | 1 line | CDDP + gemcitabine | 3 |
Pat 14 | 52 | GC | July 2015 | 1 line | Paclitaxel + ramucirumab | 3 |